New Reduced Drinking Goals in Alcohol Pharmacotherapy Trials—A Novel Public-Private Effort and FDA Approval Process

This Viewpoint describes the work of a public-private partnership to establish a reduced drinking level–based end point for clinical trials of alcohol use disorder treatment.

Corresponding Author: Raymond F. Anton, MD, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 1739 Live Oak Park, Johns Island, SC 29455 (antonr@musc.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.